Login / Signup
Nomograms confirm serum IL-6 and CRP as predictors of immune checkpoint inhibitor efficacy in unresectable hepatocellular carcinoma.
Jiajia Du
Zhiyong Huang
Erlei Zhang
Published in:
Frontiers in immunology (2024)
Low levels of IL-6 and CRP have a positive correlation with efficacy for uHCC patients receiving ICIs.
Keyphrases
</>
locally advanced